MPT0G211
MPT0G211 is a potent, orally active and selective HDAC6 inhibitor (IC50=0.291 nM) . MPT0G211 displays >1000-fold selective for HDAC6 over other HDAC isoforms. MPT0G211 can penetrate the blood-brain barrier. MPT0G211 ameliorates tau phosphorylation and cognitive deficits in an Alzheimer’s disease model. MPT0G211 has anti-metastatic and neuroprotective effects. Anticancer activities[1][2][3].
Product Specifications
CAS Number
2151853-97-1
UNSPSC
12352005
Target
HDAC
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/mpt0g211.html
Purity
99.79
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NO)C1=CC=C(CNC2=C3N=CC=CC3=CC=C2)C=C1
Molecular Formula
C17H15N3O2
Molecular Weight
293.32
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC6
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Hexokinase 1/HK1 Rabbit Polyclonal Antibody (Fluoro647)
Zfp131 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
OTC/Ornithine Carbamoyltransferase Polyclonal Antibody, PerCP Conjugated
